Jevtana (cabazitaxel)

pCPA File Number: 21020

Negotiation Status:

Concluded with an LOI

Indication(s):

Metastatic Castration-Resistant Prostate Cancer

Sponsor/Manufacturer:

Sanofi-Aventis Canada Inc.

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2018-02-28

Negotiation Process Concluded:

2018-11-07